Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension. 2018

Karen M Olsson, and Marius M Hoeper
Dept of Respiratory Medicine, Hannover Medical School and German Center of Lung Research (DZL), Hannover, Germany.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis
D018570 Risk Assessment The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988) Assessment, Risk,Benefit-Risk Assessment,Risk Analysis,Risk-Benefit Assessment,Health Risk Assessment,Risks and Benefits,Analysis, Risk,Assessment, Benefit-Risk,Assessment, Health Risk,Assessment, Risk-Benefit,Benefit Risk Assessment,Benefit-Risk Assessments,Benefits and Risks,Health Risk Assessments,Risk Analyses,Risk Assessment, Health,Risk Assessments,Risk Benefit Assessment,Risk-Benefit Assessments
D065627 Familial Primary Pulmonary Hypertension Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease. Heritable Pulmonary Arterial Hypertension,Idiopathic Pulmonary Arterial Hypertension,Idiopathic Pulmonary Hypertension,Pph1 With Hht,Primary Pulmonary Hypertension,Pulmonary Hypertension, Primary, 1,Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia,Pulmonary Hypertension, Primary, Dexfenfluramine-Associated,Pulmonary Hypertension, Primary, Fenfluramine-Associated,Hypertension, Idiopathic Pulmonary,Hypertension, Primary Pulmonary,Pulmonary Hypertension, Idiopathic,Pulmonary Hypertension, Primary

Related Publications

Karen M Olsson, and Marius M Hoeper
October 2018, The European respiratory journal,
Karen M Olsson, and Marius M Hoeper
October 2022, The international journal of cardiovascular imaging,
Karen M Olsson, and Marius M Hoeper
February 2008, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Karen M Olsson, and Marius M Hoeper
April 2018, The European respiratory journal,
Karen M Olsson, and Marius M Hoeper
January 2020, Integrated blood pressure control,
Karen M Olsson, and Marius M Hoeper
December 2006, Presse medicale (Paris, France : 1983),
Karen M Olsson, and Marius M Hoeper
April 2021, Presse medicale (Paris, France : 1983),
Karen M Olsson, and Marius M Hoeper
September 2010, Autoimmunity reviews,
Copied contents to your clipboard!